CAR T-cell Therapy: Weaponizing the Immune System to Fight Cancer

CAR T-cell therapy is a type of immunotherapy where a patient’s own T-cells are genetically engineered to help their immune system fight the cancer. With two treatments currently available in the market, KYMRIAH® and YESCARTA®, CAR T-cell therapy is already delivering significant results for patients with certain blood cancers. As research continues on this groundbreaking therapy, it holds great promise for other types of cancer as well. To learn more about CAR T-cell therapy, what it is, the challenges and future promise it has for the health care industry, read our white paper below.